Endo Pharmaceuticals Agrees to Acquire Penwest Pharmaceuticals and Submits NDA ... - PR Newswire (press release) Print
PR Newswire (press release)OPANA ER should be used with caution in patients with mild hepatic impairment and in patients with moderate to severe renal impairment.

... read more